Skip to main content
. Author manuscript; available in PMC: 2009 Sep 15.
Published in final edited form as: Clin Cancer Res. 2008 May 1;14(9):2647–2655. doi: 10.1158/1078-0432.CCR-07-1442

Figure 3. Comparison of diagnostic performance of Bb/pAb and mAb bead-based assays in the serum subset (n=214) and in the full serum set (n=336) for cases vs. controls, cases vs. healthy controls, and cases vs. surgical controls.

Figure 3

A, ROCs for HE4 B, ROC's for mesothelin C, ROCs for HE4 Bb/pAb assay D, ROCs for mesothelin Bb/pAb assay.